Pregnancy-associated plasma protein A in non-cardiac conditions

Kasper Karmark Iversen*, Ane Sogaard Teisner, Borge Teisner, Anette Kliem, Morten Bay, Vibeke Kirk, Henrik Nielsen, Soren Boesgaard, Peer Grande, Peter Clemmensen

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review


    Objective: PAPP-A is a promising new marker in coronary heart disease. It is important to investigate its specificity in order to establish its clinical utility as a marker of coronary heart disease. Design and methods: PAPP-A was measured within 24 h following hospital admission in 1448 consecutive patients admitted with diagnoses other than acute coronary syndromes. Results: PAPP-A was detectable (≥ 4.0 mIU/L) in 278 (19.2%) patients, among whom the mean level was 6.3 mIU/L (95% C.I., 6.1-6.5 mIU/L). The 95 and 99 percentiles for PAPP-A were 7.3 and 9.4 mIU/L, respectively. There was no difference in the mean PAPP-A of different diagnoses (p = 0.33). None of the specific diagnoses known to influence established coronary markers appeared to influence the level of circulating PAPP-A. Conclusion: PAPP-A is low in patients without known coronary heart disease. PAPP-A levels seem to be a potentially highly specific marker for heart disease.

    Sider (fra-til)548-553
    Antal sider6
    TidsskriftClinical Biochemistry
    Udgave nummer7-8
    StatusUdgivet - 1 maj 2008


    Udforsk hvilke forskningsemner 'Pregnancy-associated plasma protein A in non-cardiac conditions' indeholder.